ScienceDaily reports a small study used omalizumab, an allergy drug, in tandem with increased exposure to milk to desensitize children’s milk allergies.
Immunologists and allergists at Children’s Hospital Boston and the Stanford University School of Medicine completed the small study. About 2.5 percent of children under age 3 have a milk allergy, making it the most common allergy for children in the U.S. Following the study, most of the patients could pass a double-blind food challenge, ingesting the equivalent of at least 8 ounces of milk per day.
By combining the children’s exposure to milk with the allergy drug children could build up resistance with limited allergic reactions. The treatment schedule was presented Monday at the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Francisco.